Differential expression of glutamate receptors by the dopaminergic neurons of the primate striatum

Experimental Neurology

Volumn 159, Issue 2, 1999, Pages 401-408

  Betarbet, Ranjita ^a   Greenamyre, J Timothy ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Dopaminergic cells; GluR2; Metabotropic receptors; MPTP; NR1; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR;

ADOLESCENT; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; EXCITABILITY; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; THALAMUS;

EID: 0032865254     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7154     Document Type: Article

References (61)

1. 2+ signal transduction. J. Biol. Chem. 267:1992;13361-13368.
2. Albin R. L., Young A. B., Penny J. B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
3. Bardoul M., Levallois C., Konig N. Functional AMPA/kainate receptors in human embryonic and foetal central nervous system. J. Chem. Neuroant. 14:1998;79-85.
4. Beal M. F. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6:1992;3338-3344.
5. Bear M. F., Dudek S. M. Stimulation of phosphoinositide turnover by excitatory amino acids. Pharmacology, development, and role in visual cortical plasticity. Ann. N. Y. Acad. Sci. 627:1991;42-56.
6. Bernard V., Somogyi P., Bolam J. P. Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J. Neurosci. 17:1997;819-833.
7. Betarbet R., Turner R., Chockkan V., DeLong M. R., Allers K. A., Walters J., Levey A. I., Greenamyre J. T. Dopaminergic neurons intrinsic to the primate striatum. J. Neurosci. 17:1997;6761-6768.
8. Blandini F., Greenamyre J. T., Nappi G. The role of glutamate in the pathophysiology of Parkinson's disease. Funct. Neurol. 11:1996;3-15.
9. Boulter J., Bettler B., Dingledine R., Egebjerg J., Hartley M., Hermans-Borgmeyer I., Hollmann M., Hume R. I., Rogers S., Heinemann S. Molecular biology of glutamate receptors. Clin. Neuropharmacol. 15:1992;60A-61A.
10. Camon L., Vives P., de Vera N., Martinez E. Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine. J. Neurosci. Res. 51:1998;339-348.
11. 2+ rises and consequent oxygen radical production. J. Neurosci. 18:1998;7727-7738.
12. Catania M. V., Tolle T. R., Monyer H. Differential expression of AMPA receptor subunit in NOS-positive neurons of cortex, striatum and hippocampus. J. Neurosci. 15:1995;7046-7061.
13. Chen Q., Veenman C. L., Reiner A. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience. 73:1996;715-731.
14. Cheramy A., Romo R., Godeheu G., Baruch P., Glowinski J. In vivo presynaptic control of dopamine release in the cat caudate nucleus. II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience. 19:1986;1081-1090.
15. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
16. Ehringer H., Hornykiewicz O. Verteilung von noradrenalin und dopamin (3-hydroxy-tyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klinische Wochenschrift. 1960;1236-1239.
17. Gallo V., Pende M., Scherer S., Molné M., Wright P. Expression and regulation of kainate and AMPA receptors in uncommitted and committed neural progenitors. Neurochem. Res. 20:1995;549-560.
18. Gasic G. P., Hollmann M. Molecular neurobiology of glutamate receptors. A Rev. Physiol. 54:1992;507-536.
19. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron. 15:1995;193-204.
20. Gerfen C. R., Wilson C. J. The basal ganglia. Swanson L. W., Bjorklund A., Hokfelt T. Handbook of Chemical Neuroanatomy. 1996;371-468 Elsevier, Amsterdam.
21. Giorguieff M. F., Kemel M. L., Glowinski J. Presynaptic effect of l-glutamic acid on the release of dopamine in rat striatal slices. Neurosci. Lett. 6:1977;73-77.
22. Gotz T., Kraushaar U., Geiger J., Lubke J., Berger T., Jonas P. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J. Neurosci. 17:1997;204-215.
23. Gould E., Cameron H. A., McEwen B. S. J. Blockade of NMDA receptor increases cell death and birth in the developing rat dentate gyrus. J. Comp. Neurol. 340:1994;551-565.
24. Hollmann M., Boulter J., Cornelia C., Beasley L., Sullivan J., Pecht G., Heinemann S. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron. 10:1993;943-954.
25. Hollmann M., Heineman S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
26. Hollmann M., Hartley M., Heinemann S. Ca++ permeability of KA-AMPA-gated glutamate receptor channel depends on the subunit composition. Science. 252:1991;851-853.
27. Houamed K. M., Kuijper T. L., Gilbert T. L., Haldeman B. A., O'Hara P. J., Mulvihill E. R., Almers W., Hagen F. S. Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from the rat brain. Science. 252:1991;1318-1321.
28. 28k-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Mol. Brain Res. 13:1992;251-261.
29. Imperato A., Honoré T., Jensen L. H. Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: A study in free moving rats. Brain Res. 530:1990;223-228.
30. 28k in the basal ganglia of patients with Parkinsonism. Ann. Neurol. 32:1992;543-550.
31. Jackson T. R., Blader I. J., Hammonds-Odie L. P., Burga C. R., Cooke F., Hawkins P. T., Wolf A. G., Heldman K. A., Theibert A. B. Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of phosphoinositide 3-kinase. J. Cell. Sci. 109:1996;289-300.
32. Jia Z., Agopyan N., Miu P., Xiong Z., Henderson J., Gerlai R., Taverna F. A., Velumian A., MacDonald J., Carlen P., Abramow-Newerly W., Roder J. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron. 17:1996;945-956.
33. Johansen F. F., Jorgensen M. B., Diemer N. H. Resistance of hippocampal CA-1 interneurons to 20 min of transient cerebral ischemia in the rat. Acta Neuropathol. 61:1983;135-140.
34. Kerner J. A., Standaert D. G., Penney J. B. Jr., Young A. B., Landwehrmeyer G. B. Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus. Mol. Brain Res. 48:1997;259-269.
35. Krebs M-O., Trovero F., Desban M., Gauchy C., Glowinski J., Kemel M-L. Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum. J. Neurosci. 11:1991;1256-1262.
36. Lambolez B., Ropert N., Perrais D., Rossier J., Hestrin S. Correlation between kinetics and RNA splicing of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor in neocortical neurons. Proc. Natl. Acad. Sci. USA. 93:1996;1797-1802.
37. Lavoie B., Parent A. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. NeuroReport. 2:1991;601-604.
38. Martin L. J., Blackstone C. D., Huganir R. L., Price D. L. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron. 9:1992;259-270.
39. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 349:1991;760-765.
40. Miller S., Romano C., Cotman C. W. Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes. J. Neurosci. 15:1995;6103-6109.
41. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
42. Nakanishi S., Masu M. Molecular diversity and functions of glutamate receptors. Annu. Rev. Biophys. Biomol. Struct. 23:1994;319-348.
43. Okamoto N., Hori S., Akazawa C., Hayashi Y., Shigemoto R., Mizuno N., Nakanishi S. Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J. Biol. Chem. 269:1994;1231-1236.
44. Paquet M., Tremblay M., Soghomonian J-J., Smith Y. AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: An immunohistochemical and in situ hybridization study. J. Neurosci. 17:1997;1377-1396.
45. Petralia R. S., Yokotani N., Wenthold R. J. Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J. Neurosci. 14:1994;667-696.
46. Pin J. P., Duvoisin R. The metabotropic glutamate receptors: Structure and function. Neuropharmacology. 34:1995;1-26.
47. Plenz D., Kitai. Regulation of nigrostriatal pathway by metabotropic glutamate receptors during development. J. Neurosci. 18:1998;4133-4144.
48. Rakic P., Cameron R. S., Komuro H. Recognition, adhesion, transmembrane signaling and cell motility in guided neuronal migration. Curr. Opin. Neurobiol. 4:1994;63-69.
49. 3H]dopamine from rat striatal slices. Neurosci. Lett. 96:1989;323-328.
50. 3H]dopamine release from rat striatum: An in vitro model for glutamate actions. J. Neurochem. 32:1979;1539-1545.
51. Rodriguez M. C., Obeso J. A., Olanow C. W. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection. Ann. Neurol. 44:1998;S175-S188.
52. Seeburg P. H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16:1993;359-365.
53. Shigemoto R., Nomura S., Ohishi H., Sugihara H., Nakanishi S., Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci. Lett. 163:1993;53-57.
54. Shindler K. S., Roth K. A. Double immunofluorescent staining using two unconjugated primary antisera raised in same species. J. Histochem. Cytochem. 44:1996;1331-1335.
55. Sommer B., Seeburg P. H. Glutamate receptor channels: Novel properties and new clones. Trends Pharmacol. Sci. 13:1992;291-296.
56. Spitzer N. C., Gu X., Olson E. Action potentials, calcium transients and the control of differentiation of excitable cells. Curr. Opin. Neurobiol. 4:1994;70-77.
57. +) nigral toxicity in the rat by prior decortication or MK-801 treatment: A stereological estimate of neuronal loss. Neurobiol. Aging. 14:1993;295-301.
58. Strasser U., Lobner D., Behrens M. M., Canzoniero L. M., Choi D. W. Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures. Eur. J. Neurosci. 10:1998;2848-2855.
59. Tallaksen-Greene S. J., Kaatz K. W., Romano C., Albin R. L. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res. 780:1998;210-217.
60. Tanabe Y., Masu M., Ishii T., Shigemoto R., Nakanishi S. A family of metabotropic receptors. Neuron. 8:1992;169-179.
61. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature. 349:1991;414-418.